Literature DB >> 21411287

Full-scale scores of the Mini Mental State Examination can be generated from an abbreviated version.

Fiona E Matthews1, Blossom C M Stephan, Kay-Tee Khaw, Shabina Hayat, Robert Luben, Amit Bhaniani, Stephanie Moore, Carol Brayne.   

Abstract

OBJECTIVE: To determine whether the full Mini Mental State Examination (MMSE) scale range can be derived from an abbreviated 11-item version that was designed for testing general cognitive function in a cohort where only a small proportion were expected to be severely impaired or demented. STUDY DESIGN AND
SETTING: Using simple computation and multiple imputation, the properties of the abbreviated MMSE were compared with the full MMSE score using data from the Medical Research Council Cognitive Function and Ageing Study.
RESULTS: Full MMSE scores can be generated for the abbreviated version by assuming high functioning on excluded items. Of the imputed scores, 88.8% were within 1 point of their true value. When the sample was restricted to individuals with normal cognitive functioning (MMSE total score ≥ 24/30), 96.7% of individuals were classified within 1 point of their true total score. The model worked best at predicting cognitive level when cutoff scores were used to classify individuals into impaired vs. not nonimpaired.
CONCLUSION: Full-scale MMSE scores can be reasonably accurately derived from an 11-item abbreviated version. This reduced version can be applied within other frameworks that require reduced test length but need results that are comparable to studies where the full version has been administered.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21411287     DOI: 10.1016/j.jclinepi.2010.11.014

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Does the Abbreviated Mental Test Accurately Predict Cognitive Impairment in Thai Older Adults? A Retrospective Study.

Authors:  Kamonthip Tanglakmankhong; Benjamin M Hampstead; Robert J Ploutz-Snyder; Kathleen Potempa
Journal:  Pac Rim Int J Nurs Res Thail       Date:  2020-12-08

2.  Three-question dementia screening. Development of the Salzburg Dementia Test Prediction (SDTP).

Authors:  A K Kaiser; W Hitzl; B Iglseder
Journal:  Z Gerontol Geriatr       Date:  2014-11       Impact factor: 1.281

3.  Cognitive function in a general population of men and women: a cross sectional study in the European Investigation of Cancer-Norfolk cohort (EPIC-Norfolk).

Authors:  Shabina A Hayat; Robert Luben; Stephanie Moore; Nichola Dalzell; Amit Bhaniani; Serena Anuj; Fiona E Matthews; Nick Wareham; Kay-Tee Khaw; Carol Brayne
Journal:  BMC Geriatr       Date:  2014-12-19       Impact factor: 3.921

4.  Helicobacter pylori, Vascular Risk Factors and Cognition in U.S. Older Adults.

Authors:  Víctor M Cárdenas; François Boller; Gustavo C Román
Journal:  Brain Sci       Date:  2019-12-12

5.  Cognitive screening assessment in Thai older adults: a prospective study of the reliability and validity of the Abbreviated Mental Test.

Authors:  Kamonthip Tanglakmankhong; Benjamin M Hampstead; Robert J Ploutz-Snyder; Kathleen Potempa
Journal:  J Health Res       Date:  2021-02-18

6.  Cohort profile: A prospective cohort study of objective physical and cognitive capability and visual health in an ageing population of men and women in Norfolk (EPIC-Norfolk 3).

Authors:  Shabina A Hayat; Robert Luben; Victoria L Keevil; Stephanie Moore; Nichola Dalzell; Amit Bhaniani; Anthony P Khawaja; Paul Foster; Carol Brayne; Nicholas J Wareham; Kay-Tee Khaw
Journal:  Int J Epidemiol       Date:  2013-06-14       Impact factor: 7.196

7.  Retinal Nerve Fiber Layer Measures and Cognitive Function in the EPIC-Norfolk Cohort Study.

Authors:  Anthony P Khawaja; Michelle P Y Chan; Jennifer L Y Yip; David C Broadway; David F Garway-Heath; Robert Luben; Shabina Hayat; Fiona E Matthews; Carol Brayne; Kay-Tee Khaw; Paul J Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.